The Landscape of GLP-1 Prescriptions in Germany: A Comprehensive GuideThe pharmaceutical landscape in Germany has gone through a considerable shift over the last 2 years, driven mostly by the worldwide rise in need for GLP-1 (Glucagon-like peptide-1) receptor agonists. Originally developed to deal with Type 2 diabetes, these medications have
